OEM News

Solid Growth Forecast for China’s Atherectomy Devices Market

Country ranked second in value in the Asia-Pacific region last year.

By: Michael Barbella

Managing Editor

The artherectomy devices market in China is primed for steady growth over the next decade, thanks to the universal factors driving the increasing prevalence of peripheral artery disease (PAD) worldwide.

GlobalData estimates the sector to grow 9% annually between 2023 and 2033 due to China’s aging population, sedentary lifestyles, poor eating habits, and a growing demand for non-invasive endovascular procedures. 

GlobalData’s report, “Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033,” indicates that China was the second-largest atherectomy devices market by value in the Asia-Pacific region in 2023, comprising almost 16% of the total sector.

“There is an urgent need for innovative solutions to manage significant burden of PAD in China. This need creates substantial growth and expansion opportunities for both local and international players investing in China’s atherectomy devices market,” GlobalData Medical Devices Analyst Rachna Tripathi commented. 

In March this year, Avinger Inc, entered into a strategic partnership with Zylox-Tonbridge to localize and distribute its Optical Coherence Tomography (OCT)-guided devices throughout greater China. The collaboration offers Avinger a substantial investment opportunity to expand its coverage in the Chinese market as well as the chance to distribute premium peripheral vascular products made by Zylox in Germany and the United States. This partnership will allow Zylox to address the rising disease burden in China by offering more affordable and superior OCT-guided vascular treatment solutions.

“Steep learning curve for healthcare professionals, high costs, and side effects such as distal embolization, vascular trauma, and increased procedural time are some of the challenges in this market,” Tripathi noted. “Strategic partnerships to advance technology, accessibility, affordability, safety, and user-friendliness are expected to address these challenges and propel market growth.”

 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters